The rationale for the study was anecdotal reports of the effects of breast milk used by mothers to treat blocked tear ducts, ...

Topical ABT-263 effectively reduced several senescence markers in aged skin, preparing it for improved wound healing.

The skin serves as the body's primary defense against harmful microorganisms, toxins, and physical damage. However, severe ...

A major challenge in self-powered wearable sensors for health care monitoring is distinguishing different signals when they ...

MediWound , an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase III trial for its treatment for venous leg ulcers.

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

A major challenge in self-powered wearable sensors for health care monitoring is distinguishing different signals when they occur at the same time. Researchers from Penn State and China’s Hebei ...

MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...

leading to problems such as delayed wound healing, inflammation, neovascularization, and even necrosis. Moreover, this negatively charged 3D DNA supramolecular framework can guide the adsorption ...

YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...

and inflammation, in view of these binding capacities to various RAR receptors. Tazarotene down-regulates the abnormal expression of keratinocytes, epidermal growth factor receptor, and ...

Oleogel-S10 is an effective and well-tolerated long-term treatment for epidermolysis bullosa, including patients with severe forms of the disease.